Bettina M. Cockroft, M.D., M.B.A.
Board Member
CNS Pharmaceuticals, Inc. (CNSP)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Bettina M. Cockroft, M.D., M.B.A.
Bettina M. Cockroft, M.D., M.B.A. is recorded as Board Member at CNS Pharmaceuticals, Inc. (CNSP). CNS Pharmaceuticals, Inc. reported in an 8-K filed May 8, 2023 that Bettina M. Cockroft, M.D., M.B.A. was appointed independent member of the Company's Board of Directors, effective May 3, 2023.
“On May 3, 2023, the Board of Directors of CNS Pharmaceuticals, Inc. (the “Company”) appointed Bettina M. Cockroft, M.D., M.B.A as an independent member of the Company’s Board of Directors effective on such date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-05-03–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at CNS Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Rami Levin CEO, Board Member
- Faith Charles Chairman, Board Member
- Steve O'Loughlin CFO
- Eric Faulkner CTO
- Amy Mahery Board Member
- Bettina Cockroft Board Member
- Faith L. Charles Board Member
- Jeff Keyes Board Member
- Jeffrey Keyes Board Member
- Jeffry R. Keyes Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.